27 results match your criteria: "Sasaki Foundation Kyoundo Hospital[Affiliation]"
Gan To Kagaku Ryoho
December 2023
Dept. of General Surgery, Sasaki Foundation Kyoundo Hospital.
A 74-year-old man with situs inversus totalis visited our hospital for a positive fecal occult blood. He was diagnosed with transverse colon cancer by total colonoscopy. We performed laparoscopic partial colectomy.
View Article and Find Full Text PDFJ Int Med Res
June 2023
Department of Internal Medicine, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan.
Bronchial asthma (BA) is a heterogeneous disease. Some patients benefit greatly from glucocorticoid (GC) treatment, whereas others are non-responders. This could be attributable to differences in pathobiology.
View Article and Find Full Text PDFCurr Oncol
November 2021
Department of Gynecology, Sasaki Foundation Kyoundo Hospital, 1-8 Kanda Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
This study aimed to assess the accuracy of predicting pelvic lymph node status using sentinel lymph node (SLN) biopsy with indocyanine green (ICG) and to examine the outcomes of SLN biopsy-guided abdominal radical trachelectomy (ART). Patients with stage IA2-IB2 cervical cancer from January 2009 to January 2021 were included. ICG was injected before ART and SLNs were identified, excised, and assessed intraoperatively using fast-frozen sections.
View Article and Find Full Text PDFAging Clin Exp Res
September 2021
Division of General Medicine, Department of Internal Medicine, Nihon University School of Internal Medicine, Tokyo, Japan.
Background: The timed up and go (TUG) test assesses balance and mobility performance.
Aim: This study aims to investigate the association between TUG time and mortality in Japanese older persons and to clarify possible moderation effects on mortality and TUG time.
Methods: In all, 874 participants who were ≥ 65 years of age completed the TUG test and had their anthropometric parameters and physical functions measured.
Gan To Kagaku Ryoho
January 2021
Division of Surgery, Sasaki Foundation Kyoundo Hospital.
We report a case of malignant stenosis due to recurrence of lymph node metastasis treated with laparoscopic gastrojejunal bypass. A 83-year-old man who underwent chemoradiotherapy for esophageal cancer(cT3N2M0). About 3 and half years after chemoradiotherapy, he was referred to hospital for vomiting.
View Article and Find Full Text PDFAm J Hosp Palliat Care
July 2021
Department of Palliative Medicine, 68380Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Background: Neuroleptics are commonly used in palliative care settings. However, adverse events of neuroleptics, known as extrapyramidal symptoms (EPSs), might be overlooked in clinical practice. We conducted this study to explore the prevalence of EPSs in palliative care setting.
View Article and Find Full Text PDFClin Genitourin Cancer
February 2021
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Background: Second-line salvage therapy for patients with metastatic germ-cell cancer (GCC) after the first-line combination of VIP (etoposide, ifosfamide, cisplatin) therapy has not been established. This study evaluated the efficacy and tolerability of the TGP (paclitaxel, gemcitabine, cisplatin) combination chemotherapy as a second-line salvage therapy.
Patients And Methods: The medical records of 16 consecutive patients with metastatic GCC who had been treated with first-line VIP therapy followed by second-line TGP therapy between 2005 and 2019 were reviewed and statistically analyzed.
Aging Clin Exp Res
October 2020
Division of General Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Background And Aim: Disability is an important health problem among older individuals, prompting the need for long-term care. Age-related disability is usually associated with mobility; however, little is known about the association between mobility and long-term care. Therefore, this study aimed to clarify the association between the timed up and go (TUG) test measuring mobility and long-term care eligibility.
View Article and Find Full Text PDFMed Oncol
June 2019
Division of General Medicine, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi, Tokyo, 173-8610, Japan.
Nuclear receptor subfamily 4, group A, member 3 (NR4A3) is a member of the NR4A subgroup of orphan nuclear receptors, implicated in the regulation of diverse biological functions, including metabolism, angiogenesis, inflammation, cell proliferation, and apoptosis. Although many reports have suggested the involvement of NR4A3 in the development and/or progression of tumors, its role varies among tumor types. Previously, we reported that DNA hypomethylation at NR4A3 exon 3 is associated with lower survival rate of neuroblastoma (NB) patients.
View Article and Find Full Text PDFOncol Lett
April 2019
Division of General Medicine, Department of Medicine, Nihon University School of Medicine, Itabashi, Tokyo 173-8610, Japan.
Erythropoietin-producing hepatocellular (Eph) receptors and their ligand ephrins serve crucial roles in the interactions among epithelial cells. Eph receptor/ephrin signaling regulates cell functions, including proliferation, differentiation and migration, via these cell-cell interactions. We reported previously that EPHB2, a member of the Eph receptor family, was highly expressed in chemically induced cutaneous squamous cell carcinoma (cSCC) tissues in mice.
View Article and Find Full Text PDFJ Infect Chemother
July 2019
MSD KK, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, 102-8667, Japan.
This study for the first time assessed quadrivalent human papillomavirus (qHPV) vaccine effectiveness against HPV6/11/16/18-related high-grade cervical disease in Japanese women (16-26 years old), as previously demonstrated in overseas trials, and vaccine safety in a longer term (48-month) open-label study (NCT01544478). Participants received three doses of qHPV vaccine (Day 1, Month 2, Month 6). Effectiveness endpoints, assessed in the per-protocol population, included incidence of HPV6/11/16/18-related cervical intraepithelial neoplasia (CIN) Grade 2 or worse (CIN Grade 2 and 3, adenocarcinoma in situ, and/or cervical cancer) as primary endpoint and incidence of external genital lesions (EGLs).
View Article and Find Full Text PDFKorean J Anesthesiol
August 2019
Department of Anesthesiology, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan.
Strahlenther Onkol
May 2019
Japanese Foundation for Prostate Research, Tokyo, Japan.
Purpose: It is unclear whether experience at high-volume institute improves the treatment quality of prostate seed implantation. The aim of this study was to evaluate the effect of institutional experience on postimplant dosimetric parameters in a nationwide prospective cohort study.
Methods: From July 2005 to June 2007, 2354 patients were registered in the Japanese Prostate Cancer Outcome Study of Permanent I‑125 Seed Implantation (J-POPS), and 1126 patients treated with seed implantation alone were evaluated.
Oncol Lett
November 2018
Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.
As cancer susceptibility varies among mouse strains, mouse models are powerful tools for the identification of genes responsible for cancer development. Several cancer susceptibility loci have been mapped by genetic analysis using cancer-resistant and cancer-susceptible mouse strains. However, only a few corresponding genes for these loci have been identified, because most of the cancer susceptibility loci are low-penetrance alleles.
View Article and Find Full Text PDFCase Rep Urol
June 2018
Department of Urology, Kanagawa Cancer Center, Yokohama, Japan.
A 56-year-old man was admitted to our hospital for urachal carcinoma with peritoneal dissemination. He received first-line chemotherapy with gemcitabine and cisplatin. After the fifth cycle, a computed tomography (CT) scan revealed abdominal fluid, and his serum tumor marker levels were increased.
View Article and Find Full Text PDFLiver Cancer
May 2018
Department of Hepatology, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan.
Background: An unmet need exists for treatment of patients with advanced hepatocellular carcinoma (HCC) who progress on or are intolerant to sorafenib. A global randomized phase II trial (ClinicalTrial.gov No.
View Article and Find Full Text PDFJ Infect Dis
June 2018
Merck & Co., Inc., Kenilworth, New Jersey.
Background: A 9-valent human papillomavirus-6/11/16/18/31/33/45/52/58 (9vHPV) vaccine extends coverage to 5 next most common oncogenic types (31/33/45/52/58) in cervical cancer versus quadrivalent HPV (qHPV) vaccine. We describe efficacy, immunogenicity, and safety in Asian participants (India, Hong Kong, South Korea, Japan, Taiwan, and Thailand) from 2 international studies: a randomized, double-blinded, qHPV vaccine-controlled efficacy study (young women aged 16-26 years; NCT00543543; Study 001); and an immunogenicity study (girls and boys aged 9-15 years; NCT00943722; Study 002).
Methods: Participants (N = 2519) were vaccinated at day 1 and months 2 and 6.
Int Cancer Conf J
January 2018
1Department of Urology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
We report the case of a patient who achieved complete remission (CR) of cisplatin-refractory metastatic pure seminoma after treatment with high-dose carboplatin and etoposide (CE) with peripheral blood stem cell transplantation as fourth-line chemotherapy. A 38-year-old man was diagnosed with advanced pure seminoma (pT3N3M1aS3). In the international germ cell consensus classification, his prognosis was classified as intermediate.
View Article and Find Full Text PDFJuvenile nasopharyngeal angiofibroma (JNA) involves difficult anesthetic management because of the risk of massive bleeding, while airway management is rarely a problem in JNA. This report presents an unusual case of JNA causing airway obstruction.
View Article and Find Full Text PDFYakugaku Zasshi
September 2017
Division of Hospital Pharmacy, Sasaki Foundation Kyoundo Hospital.
Steroid ointments are frequently mixed with moisturizer. It was reported that steroid ointments mixed with moisturizer increase permeability. There are only few studies done on the permeability of the moisturizer.
View Article and Find Full Text PDFInt J Cancer
September 2017
Department of Obstetrics and Gynecology, Iwate Medical University, Iwate, Japan.
This was a nation-wide retrospective study in Japan examining women who underwent radical hysterectomy for clinical stage IB-IIB cervical cancer with pelvic and/or para-aortic lymph node metastasis between 2004 and 2008. Time to recurrence or death and patterns of disease recurrence were compared based upon the adjuvant treatment pattern: whole pelvic radiotherapy alone (n = 253), concurrent chemoradiotherapy (CCRT, n = 502) and chemotherapy alone (n = 319). Women who received chemotherapy alone had similar recurrence (5-year rates, 36.
View Article and Find Full Text PDFGynecol Minim Invasive Ther
January 2017
Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
Study Objective: To describe Higuchi's transverse incision and a modification of this method for reduced port surgery (RPS).
Design: Descriptive study.
Setting: University hospital.
Gynecol Minim Invasive Ther
June 2016
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
Objective: Higuchi's transverse incision is made at a lower position than the Pfannenstiel transverse incision and is superior in terms of cosmetic outcomes. The purpose of this study was to examine the safety and efficacy of novel forms of reduced port surgery for ovarian cysts and uterine fibroids applying Higuchi's transverse incision.
Methods: In 33 patients with ovarian cysts who underwent low-position single-incision laparoscopic surgery (L-SILS)-modified single-port laparoscopy placed in the 2-3-cm Higuchi's incision above the pubis, patient's characteristics and perioperative outcomes were compared with those of patients who underwent multiport laparoscopy ( = 53).
Ann Oncol
December 2015
Department of Gastroenterology and Hepatology, Kinki University Hospital, Osaka, Japan.
Background: The efficacy and safety of axitinib, a potent and selective vascular endothelial growth factor receptors 1-3 inhibitor, combined with best supportive care (BSC) was evaluated in a global, randomized, placebo-controlled phase II trial in patients with locally advanced or metastatic hepatocellular carcinoma (HCC).
Patients And Methods: Patients with HCC and Child-Pugh Class A who progressed on or were intolerant to one prior antiangiogenic therapy were stratified by tumour invasion (presence/absence of extrahepatic spread and/or vascular invasion) and region (Asian/non-Asian) and randomized (2:1) to axitinib/BSC (starting dose 5 mg twice-daily) or placebo/BSC. The primary end point was overall survival (OS).
Int J Gynecol Cancer
September 2014
*Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Kanagawa; †Department of Obstetrics and Gynecology, Graduate School of Medicine, University of the Ryukyus, Nishihara; ‡Department of Gynecology, Sasaki Foundation Kyoundo Hospital, Tokyo; §Department of Obstetrics and Gynecology, Tottori University School of Medicine, Tottori; ∥Departments of Gynecology, Cancer Institute Hospital, Tokyo; ¶Department of Obstetrics and Gynecology, Hiroshima University Graduate School of Medicine, Hiroshima; #Department of Obstetrics and Gynecology, Ehime University School of Medicine, Ehime; and **Department of Obstetrics and Gynecology, Nara Prefectural Hospital, Nara, Japan.
Objective: The aim of this study was to determine the current operative management of International Federation of Gynecology and Obstetrics (FIGO) stage IB2, IIA2, and IIB uterine cervical cancer (bulky tumors) in Japan by surveying the member institutions of the Japanese Gynecologic Oncology Group.
Methods: We conducted a survey to assess current operative management, including indications and treatment, at all 199 active member institutions of the Japanese Gynecologic Oncology Group.
Results: A total of 166 institutions (83.